These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 32313760

  • 1. Differences in Response to Recombinant Growth Hormone Therapy on Height Gain in Patients with Idiopathic Short Stature Vs. Patients with Growth Hormone Deficiency.
    Alzahrani AK, Algethami AK, Barnawi G, Meftah IA, Alshanqiti A, Al-Hashmi H, Khan MA, Felimban N.
    Cureus; 2020 Mar 18; 12(3):e7319. PubMed ID: 32313760
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L, Liang Y, Wu W, Lin HH, Luo XP, Ying YQ.
    Growth Horm IGF Res; 2020 Mar 18; 53-54():101331. PubMed ID: 32777706
    [Abstract] [Full Text] [Related]

  • 4. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A, Daftardar H, Alghamdi AA, Jamjoom M, Awidah S, Ahmed ME, Soliman AT.
    Acta Biomed; 2020 Mar 19; 91(1):29-40. PubMed ID: 32191651
    [Abstract] [Full Text] [Related]

  • 5. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A, Rogol AD, Elsiddig S, Khalil A, Alaaraj N, Alyafie F, Ahmed H, Elawwa A.
    J Pediatr Endocrinol Metab; 2021 Oct 26; 34(10):1263-1271. PubMed ID: 34291621
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beyond Growth Hormone: Association of Short Stature Types and Growth Hormones With Scoliosis.
    Hong H, Hu J, Xu H, Xia D, Pan X, Chen X, Guo Q, Zhang S, Chen J, Wu Y, Leng H, Zhang X, Wang X, Huang C.
    Spine (Phila Pa 1976); 2024 Feb 15; 49(4):221-231. PubMed ID: 37871182
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of recombinant human growth hormone in the treatment of dwarfism and relationship between IGF-1, IGFBP-3 and thyroid hormone.
    Ren S, Nie Y, Wang A.
    Exp Ther Med; 2016 Dec 15; 12(6):3579-3582. PubMed ID: 28105090
    [Abstract] [Full Text] [Related]

  • 13. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov 15; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 14. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
    Wassenaar MJ, Dekkers OM, Pereira AM, Wit JM, Smit JW, Biermasz NR, Romijn JA.
    J Clin Endocrinol Metab; 2009 Oct 15; 94(10):3721-30. PubMed ID: 19584188
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group.
    J Clin Endocrinol Metab; 2010 May 15; 95(5):2089-98. PubMed ID: 20207829
    [Abstract] [Full Text] [Related]

  • 17. Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency.
    Yoon JY, Cheon CK, Lee JH, Kwak MJ, Kim HJ, Kim YJ, Lee JE, Chung WY, Kim J, Yoo JH.
    Ann Pediatr Endocrinol Metab; 2022 Mar 15; 27(1):37-43. PubMed ID: 35038835
    [Abstract] [Full Text] [Related]

  • 18. Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System.
    Rashid N, Saenger P, Wu YL, Woehling H, Frankel M, Lifshitz F, Muenzberg M, Rapaport R.
    Biol Ther; 2014 Dec 15; 4(1-2):27-39. PubMed ID: 25096555
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ, Wang LH, Chen L.
    Adv Ther; 2019 Sep 15; 36(9):2374-2383. PubMed ID: 31301056
    [Abstract] [Full Text] [Related]

  • 20. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z, Li YH, Ma HM, Chen HS, DU ML, Gu YF.
    Zhonghua Er Ke Za Zhi; 2008 Oct 15; 46(10):757-62. PubMed ID: 19099881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.